Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

BACKGROUND: A number of clinical studies focused on treating a single food allergy through oral immunotherapy (OIT) with adjunctive omalizumab treatment have been published. We previously demonstrated safety and tolerability of a rapid OIT protocol using omalizumab in a phase 1 study to achieve dese...

Descripción completa

Detalles Bibliográficos
Autores principales: Andorf, Sandra, Manohar, Monali, Dominguez, Tina, Block, Whitney, Tupa, Dana, Kshirsagar, Rohun A., Sampath, Vanitha, Chinthrajah, R. Sharon, Nadeau, Kari C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738812/
https://www.ncbi.nlm.nih.gov/pubmed/29296107
http://dx.doi.org/10.1186/s13223-017-0223-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738812/
https://www.ncbi.nlm.nih.gov/pubmed/29296107
http://dx.doi.org/10.1186/s13223-017-0223-8

Ejemplares similares